Skip to main content
Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
165.04
+8.39 (5.36%)
At close: Nov 13, 2026, 4:00 PM EST
165.91
+0.87 (0.53%)
After-hours: Nov 13, 2026, 7:59 PM EST

Alnylam Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
2,649313.75-278.16-440.24-1,131-852.82
Depreciation & Amortization
55.4355.6656.6754.0544.4789.69
Loss (Gain) From Sale of Investments
-2.313.0216.9433.31-55.7
Stock-Based Compensation
307.53348.24272.08221.68230.65165.72
Other Operating Activities
-1,608248.92152.15194.46273.84174.24
Change in Accounts Receivable
-129.05-359.96-86.55-87.94-45.6-101.8
Change in Inventory
-15.998.4713.5918.37-34.14-26.42
Change in Accounts Payable
-139.1375.0791.0980.84191.7788.24
Change in Unearned Revenue
9.13-50.64-235.4555.02-65.91-50.4
Change in Other Net Operating Assets
-173.09-117.723.23-9.03-38.51-72.45
Operating Cash Flow
955.94524.08-8.31104.16-541.27-641.69
Operating Cash Flow Growth
351.58%-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-149.64-58.7-34.28-62.21-72.06-76.37
Investment in Securities
-607.59497.18-63.25-269.7254.61-192.56
Other Investing Activities
19.33-2.15-19.32-4.44-13.19-4.36
Investing Cash Flow
-737.9436.33-116.84-336.35169.35-273.3

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-645.69--1,016500
Long-Term Debt Repaid
--1,193---880.72-
Net Debt Issued (Repaid)
-52.93-546.95--135.39500
Issuance of Common Stock
103.88250.03302.95147.46259.36246.27
Other Financing Activities
10.49-8.27-8.7924.6731500.85
Financing Cash Flow
61.44-305.19294.16172.13425.751,247

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-16.4734.94-15.246.39-7.43-9.02
Net Cash Flow
263.02690.16153.77-53.6746.4323.11

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
806.31465.38-42.5941.95-613.33-718.07
Free Cash Flow Growth
382.27%-----
Free Cash Flow Margin
16.08%12.53%-1.89%2.29%-59.12%-85.05%
Free Cash Flow Per Share
5.863.46-0.330.34-5.04-6.06
Levered Free Cash Flow
327.23128.79197.88103.55-444.3597.11
Unlevered Free Cash Flow
515.43286.68286.54179.32-346.87186.5

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
254.71218.7167.5832.1245.2424.66
Cash Income Tax Paid
48.6321.29.312.572.65-
Change in Working Capital
-448.14-444.78-214.0857.267.62-162.82
SEC Filings: 10-K · 10-Q